Expression of lectin-like oxidized LDL receptor-1 in smooth muscle cells after vascular injury

Hideyuki Eto1, Masaaki Miyata, Noriaki Kume

  • 1Department of Cardiovascular, Respiratory and Metabolic Medicine, Graduate School of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan.

Insights

Lectin-like oxidized LDL receptor-1 (LOX-1) drives smooth muscle cell proliferation and contributes to neointimal formation after vascular injury. This receptor plays a key role in restenosis following angioplasty.

Area of Science:

  • Cardiovascular Biology
  • Vascular Biology
  • Molecular Medicine

Background:

  • Lectin-like oxidized LDL receptor-1 (LOX-1) is an oxidized LDL receptor.
  • Its specific role in restenosis after angioplasty is not fully understood.

Purpose of the Study:

  • To investigate the role of LOX-1 in neointimal formation and smooth muscle cell proliferation following vascular injury.

Main Methods:

  • Balloon-injury model in rabbit aorta.
  • Reverse transcription-polymerase chain reaction (RT-PCR) for LOX-1 mRNA expression.
  • Immunohistochemistry and in situ hybridization for LOX-1 protein localization.
  • In vitro studies on cultured smooth muscle cells (SMC) with oxidized LDL (ox-LDL) and LOX-1 antisense oligonucleotides.
  • Double immunofluorescence staining for LOX-1 and proliferating cell nuclear antigen (PCNA).

Main Results:

  • LOX-1 mRNA expression peaked 2 days post-injury and remained elevated for 24 weeks.
  • LOX-1 was expressed in medial and neointimal SMCs after injury, but not in non-injured aorta.
  • Low concentrations of ox-LDL stimulated SMC proliferation, which was inhibited by LOX-1 antisense oligonucleotides.
  • LOX-1 colocalized with PCNA in human restenotic lesions.

Conclusions:

  • LOX-1 mediates ox-LDL-induced SMC proliferation.
  • LOX-1 plays a significant role in neointimal formation after vascular injury.
  • Targeting LOX-1 may be a therapeutic strategy for preventing restenosis.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Vascular Spasm01:16

Vascular Spasm

The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
Inflammation01:38

Inflammation

Overview